Viewing Study NCT05535361


Ignite Creation Date: 2025-12-24 @ 11:50 AM
Ignite Modification Date: 2026-01-01 @ 6:12 PM
Study NCT ID: NCT05535361
Status: RECRUITING
Last Update Posted: 2025-10-08
First Post: 2022-09-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome
Sponsor: Eclipse Regenesis, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Short Bowel Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None short bowel syndrome View
None intestinal failure View
None Necrotizing enterocolitis View
None short gut View
None intestinal volvulus View
None intestinal atresia View